Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21

Saved in:
Bibliographic Details
Main Authors: Kimmich, Christoph (Author) , Terzer, Tobias (Author) , Benner, Axel (Author) , Hansen, Timon (Author) , Carpinteiro, Alexander (Author) , Dittrich, Tobias (Author) , Veelken, Kaya (Author) , Jauch, Anna (Author) , Huhn, Stefanie (Author) , Basset, Marco (Author) , Goldschmidt, Hartmut (Author) , Müller-Tidow, Carsten (Author) , Schönland, Stefan (Author) , Hegenbart, Ute (Author)
Format: Article (Journal) Editorial
Language:English
Published: 2021
In: American journal of hematology
Year: 2021, Volume: 96, Issue: 7, Pages: E253-E257
ISSN:1096-8652
DOI:10.1002/ajh.26191
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ajh.26191
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ajh.26191
Get full text
Author Notes:Christoph R. Kimmich, Tobias Terzer, Axel Benner, Timon Hansen, Alexander Carpinteiro, Tobias Dittrich, Kaya Veelken, Anna Jauch, Stefanie Huhn, Marco Basset, Hartmut Goldschmidt, Carsten Müller-Tidow, Stefan O. Schönland, Ute Hegenbart
Description
Item Description:Gesehen am 21.08.2023
Physical Description:Online Resource
ISSN:1096-8652
DOI:10.1002/ajh.26191